Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00151983 · ClinicalTrials.gov registry record · Phase 3
Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy
A Phase 3 study, sponsored by Noven Therapeutics.
- Completed
- Registry status
- Phase 3
- Development phase
- 175
- Enrollment target
NCT00151983 is a Phase 3 study that has completed, run by Noven Therapeutics. The registered enrollment target is 175 participants.
The verdict
NCT00151983, a Phase 3 study, has completed, sponsored by Noven Therapeutics.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 175 participants
- Enrollment target
Study Summary
This study will assess the safety and tolerability of MTS while attempting to establish the appropriate starting dose for subjects previously on an existing long-acting methylphenidate product.
Interventions
- DRUG Methylphenidate Transdermal System
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 175 participants |
| Start Date | 2005-06 |
| Est. Completion | 2006-07 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00151983
The ClinicalTrials.gov registry entry for NCT00151983 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 175 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Noven Therapeutics, which has 10 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Methylphenidate Transdermal System is the first listed.
NCT00151983 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00151983 about?
NCT00151983 is a clinical study titled "Safety & Tolerability of MTS in Children Aged 6-12 Diagnosed With ADHD & Previously Treated With Extended-Release Methylphenidate Therapy". This study will assess the safety and tolerability of MTS while attempting to establish the appropriate starting dose for subjects previously on an existing long-acting methylphenidate product.
What is the current status of trial NCT00151983?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 175 participants. The study started on 2005-06. Estimated completion is 2006-07.
What interventions are being tested in trial NCT00151983?
The interventions under investigation include: Methylphenidate Transdermal System (DRUG).
Who is sponsoring clinical trial NCT00151983?
This trial is sponsored by Noven Therapeutics, which has 10 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.